Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T

Pharmacogenetics

Volumn 12, Issue 6, 2002, Pages 479-488

  Pan, Su Shu ^a   Han, Yusheng ^a   Farabaugh, Philip ^a   Xia, Hong ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

DT diaphorase; NAD(P)H:quinone oxidoreductase 1; Quinone reductase

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MITOMYCIN C; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; UNCLASSIFIED DRUG; DNA; NQO1 PROTEIN, HUMAN; PRIMER DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RNA; SMALL NUCLEAR RNA; U1 SMALL NUCLEAR RNA;

ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; EXON; GENE CONSTRUCT; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPLICEOSOME; CELL CULTURE; CHEMISTRY; DRUG RESISTANCE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; NAD(P)H DEHYDROGENASE (QUINONE); POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL NUCLEAR; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; HUMANS;

EID: 0036667957     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200208000-00009     Document Type: Article

References (39)

1. DT-diaphorase
2. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism
3. DT-diaphorase and cancer chemotherapy
4. Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase
5. Persuasive evidence that quinone reductase type 1 (DT-diaphorase) pretects cells against the toxicity of electrophiles and reactive forms of oxygen
6. NAD(P): Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms
7. Human dioxin-inducible cytosolic NAD(P)H:Menadione oxidoreductase-cDNA sequence and localization of gene to chromosome 16
8. Human NAD(P)H:Quinone oxidoreductase (NQO1) gene structure and induction by dioxin
9. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin C sensitivity
10. Loss of heterozygosity at the NAD(P)H:Quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line
11. Characterization of a polymorphism in NAD(P)H:Quinone oxidoreductase (DT-diaphorase)
12. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells
13. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C
14. Ethnic variation in the prevalence of a common NAD(P)H:quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
15. NAD(P)H:quinone oxidoreductase: Polymorphisms and allele frequencies in Caucasian, Chinese and Canadian native Indian and Inuit populations
16. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1
17. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase I
18. Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines
19. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate-binding site is present in human normal and tumor tissues
20. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment
21. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation
22. Primer extension
23. Cloning of hybridoma cell lines by limiting dilution
24. Isolation of nuclei by Dounce homogenization
25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
26. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
27. A multi-component complex is involved in the splicing of messenger RNA precursors
28. Interactions between small ribonucleoprotein particles in the formation of spliceosomes
29. The structure and function of proteins involved in mammalian pre-mRNA splicing
30. SR proteins and splicing control
31. Splicing of precursors to mRNAs by the spliceosomes
32. Initial splice-site recognition and pairing during pre-mRNA splicing
33. A compensatory base change in U1 snRNA suppresses a 5′-splice site mutation
34. The diverse world of small ribonucleoproteins
35. DT-diaphorase as a critical determinant of sensitivity of mitomycin C in human colon and gastric carcinoma cell lines
36. Expression of human NQO1 (DT-diaphorase) in Chinese hamster ovary cells: Effect on the toxicity of antitumor quinones
37. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase
38. Clinical significance of NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal mitomycin C
39. Clinical significance of NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C